carbamazepine has been researched along with Migraine with Aura in 2 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Migraine with Aura: A subtype of migraine disorder, characterized by recurrent attacks of reversible neurological symptoms (aura) that precede or accompany the headache. Aura may include a combination of sensory disturbances, such as blurred VISION; HALLUCINATIONS; VERTIGO; NUMBNESS; and difficulty in concentrating and speaking. Aura is usually followed by features of the COMMON MIGRAINE, such as PHOTOPHOBIA; PHONOPHOBIA; and NAUSEA. (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The paroxysmal dyskinesias are a heterogeneous group of movement disorders." | 1.35 | Oxcarbazepine use in paroxysmal kinesigenic dyskinesia: report on four patients. ( Chillag, KL; Deroos, ST, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dale, RC | 1 |
| Gardiner, A | 1 |
| Branson, JA | 1 |
| Houlden, H | 1 |
| Chillag, KL | 1 |
| Deroos, ST | 1 |
2 other studies available for carbamazepine and Migraine with Aura
| Article | Year |
|---|---|
Benefit of carbamazepine in a patient with hemiplegic migraine associated with PRRT2 mutation.
Topics: Analgesics, Non-Narcotic; Carbamazepine; Child; Family; Humans; Male; Membrane Proteins; Migraine wi | 2014 |
Oxcarbazepine use in paroxysmal kinesigenic dyskinesia: report on four patients.
Topics: Adolescent; Age of Onset; Anti-Dyskinesia Agents; Carbamazepine; Child; Developmental Disabilities; | 2009 |